Apple awards $10 million to COPAN Diagnostics to boost production of nasal swabs

Apple dips deeper into its coffers to battle coronavirus

On Thursday, Apple announced it would award $10 million from its advanced manufacturing fund to COPAN Diagnostics, a maker of nasal swabs and other materials used to collect samples for coronavirus testing. This funding will boost the swab maker’s weekly production to 1 million collection kits by early July while also supporting COPAN Diagnostics’ expansion to a new, larger facility in Southern California.

In addition to providing COPAN Diagnostics with $10 million in funding, Apple will also help the company design and source new equipment from companies like K2 Kinetics and MWES, which are makers of industrial robotics systems. 

An untimely shortage of collection kits and testing supplies have slowed coronavirus tracking efforts in the US. COPAN Diagnostics’ corporate parent, the COPAN Group, is located in the Lombardy region of Italy, one of the worst-hit regions in the world.

In a statement, Norman Sharples, chief executive of COPAN Diagnostics, shared, “Collection and transport kits are a critical component in the fight against COVID-19. At COPAN, we’re excited and grateful for this partnership with Apple as our strong beliefs of innovation, quality, and excellence in manufacturing and design are perfectly aligned. Apple’s operational expertise will help us increase delivery of important pre-analytical tools for medical professionals across the country at this critical time.”

Apple awarded the funding to COPAN Diagnostics from its $5 billion advanced manufacturing fund. The tech giant previously used the funding to support companies like iPhone glass manufacturer Corning and Finisar, the maker of chips used for Apple’s facial-recognition sensors.

“We feel a deep sense of responsibility to do everything we can to help medical workers, patients, and communities support the global response to COVID-19,” shared Apple COO, Jeff Williams. 

Apple has donated tens of millions of dollars in the coronavirus fight. Not only has the company distributed nearly 10 million face shields and sourced over 30 million face masks for health care professionals, but the iPhone maker has also teamed up with the CDC to create a COVID-19 symptom-checking website and app, and has collaborated with Google to develop COVID-19 contact-tracing technology.

Featured Resources

BCDR buyer's guide for MSPs

How to choose a business continuity and disaster recovery solution

Download now

The definitive guide to IT security

Protecting your MSP and your customers

Download now

Cost of a data breach report 2020

Find out what factors help mitigate breach costs

Download now

The complete guide to changing your phone system provider

Optimise your phone system for better business results

Download now

Recommended

Apple doubles down in the US with $430 billion investment
business intelligence (BI)

Apple doubles down in the US with $430 billion investment

27 Apr 2021
Apple patches exploited iOS and macOS WebKit flaws
zero-day exploit

Apple patches exploited iOS and macOS WebKit flaws

4 May 2021
Component shortage bites Apple, but M2 chip could still arrive soon
Hardware

Component shortage bites Apple, but M2 chip could still arrive soon

30 Apr 2021
Apple charged over breach of EU anti-competition rules
Policy & legislation

Apple charged over breach of EU anti-competition rules

30 Apr 2021

Most Popular

KPMG offers staff 'four-day fortnight' in hybrid work plans
flexible working

KPMG offers staff 'four-day fortnight' in hybrid work plans

6 May 2021
Dell patches vulnerability affecting hundreds of computer models worldwide
cyber security

Dell patches vulnerability affecting hundreds of computer models worldwide

5 May 2021
16 ways to speed up your laptop
Laptops

16 ways to speed up your laptop

29 Apr 2021